Results 241 to 250 of about 195,940 (363)

Portable Pneumatic Biventricular Driver for the Thoratec Ventricular Assist Device

open access: bronze, 1997
David J. Farrar   +3 more
openalex   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger   +15 more
wiley   +1 more source

Metabolic Reprogramming After Left Ventricular Assist Device

open access: yesJACC: Basic to Translational Science, 2016
J. Eduardo Rame, MD, MPhil   +1 more
doaj   +1 more source

In Vitro Characterization of a Magnetically Suspended Continuous Flow Ventricular Assist Device

open access: bronze, 1995
Hee Chan Kim   +5 more
openalex   +1 more source

Patch closure of the aortic anulus in a recipient of a ventricular assist device [PDF]

open access: bronze, 2000
James C. Stringham   +2 more
openalex   +1 more source

Predicting 1‐year heart failure hospitalization and mortality post‐discharge from the intensive cardiac care unit

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Despite the high risk of rehospitalization for heart failure (HF) and death among patients admitted to the intensive cardiac care unit (ICCU), no accurate prediction score for these outcomes exists. We aimed to develop a risk score to predict unplanned HF hospitalization and death 1‐year post‐discharge in an unselected cohort of patients ...
Andreas Bugge Tinggaard   +116 more
wiley   +1 more source

Course of neurohormones from heart failure to left ventricular assist device to cardiac transplantation

open access: bronze, 1996
Karen James   +5 more
openalex   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy